Advanced Heart Failure and Transplant Cardiology · Memphis, TN
NPI
1255607164
Since 2012
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6027 Walnut Grove Rd Ste 112
Memphis, TN, 38120
Phone (901) 271-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$130K
1,742 services
Medicare patients, 2024
284
Average age 69
Drug cost, 2024
$6.8M
2,295 prescriptions
Company payments, 2025
$401K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dmitry M Yaranov was code 99215 (office e&m - established), 378 times for 186 patients. In total Dmitry M Yaranov billed 1,742 services in 52 codes, and Medicare paid $130K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 378 | 186 | $121.77 | $46K |
| 99233 Hospital E&M - Subsequent | Facility | 209 | 62 | $87.34 | $18K |
| 99214 Office E&M - Established | Office | 191 | 116 | $92.19 | $18K |
| 36415 Venipuncture Blood Collection | Office | 106 | 58 | $8.65 | $917 |
| 80053 Clinical Chemistry | Office | 102 | 55 | $10.35 | $1,056 |
| 83880 Clinical Chemistry | Office | 97 | 54 | $38.37 | $3,722 |
| 93306 Echocardiography (TTE/TEE) | Facility | 94 | 56 | $50.17 | $4,716 |
| 85025 Blood Count | Office | 76 | 46 | $7.61 | $578 |
| 99205 Office E&M - New | Office | 67 | 63 | $160.65 | $11K |
| 93750 External Electrocardiographic Monitoring | Office | 63 | 32 | $36.08 | $2,273 |
| 99291 Critical Care E&M | Facility | 45 | 17 | $152.90 | $6,880 |
| 0273T External Electrocardiographic Monitoring | Office | 40 | 14 | $40.85 | $1,634 |
| 93750 External Electrocardiographic Monitoring | Facility | 27 | 12 | $28.67 | $774 |
| 99223 Hospital E&M - Initial | Facility | 27 | 24 | $127.93 | $3,454 |
| 93451 Percutaneous Transcatheterization | Facility | 25 | 23 | $77.51 | $1,938 |
By year: 2022 $172K for 2,146 services; 2023 $127K for 1,565 services; 2024 $130K for 1,742 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 106 | 58 | $8.65 | $917 |
| 80053 Clinical Chemistry | 102 | 55 | $10.35 | $1,056 |
| 83880 Clinical Chemistry | 97 | 54 | $38.37 | $3,722 |
| 85025 Blood Count | 76 | 46 | $7.61 | $578 |
| 80048 Clinical Chemistry | 18 | 13 | $8.29 | $149 |
Medicare prescription drug claims, 2024
In 2024, the drug Dmitry M Yaranov prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 251 prescriptions and refills. In total Dmitry M Yaranov wrote 2,295 Medicare prescriptions that cost $6.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 251 | 324 | 53 | $210K |
| Spironolactone Generic | 249 | 483 | 75 | $1,017 |
| Jardiance Empagliflozin | 189 | 304 | 46 | $172K |
| Vyndamax Tafamidis | 156 | 156 | 16 | $3.4M |
| Torsemide Generic | 137 | 191 | 43 | $3,088 |
| Carvedilol Generic | 134 | 254 | 38 | $607 |
| Warfarin Sodium Generic | 111 | 159 | 21 | $522 |
| Metoprolol Succinate Generic | 73 | 133 | 23 | $659 |
| Potassium Chloride Generic | 66 | 106 | 24 | $1,112 |
| Furosemide Generic | 65 | 129 | 22 | $151 |
| Wainua Eplontersen Sodium | 64 | 64 | Under 11 | $2.6M |
| Farxiga Dapagliflozin Propanediol | 62 | 92 | 18 | $51K |
| Mounjaro Tirzepatide | 57 | 57 | 11 | $58K |
| Verquvo Vericiguat | 43 | 45 | Under 11 | $29K |
| Eplerenone Generic | 42 | 64 | Under 11 | $2,915 |
Brand drugs: - claims; generic drugs: 1,293 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dmitry M Yaranov $401K ($401K in general payments such as food, travel and fees) from 20 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $145K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 83 | $145K |
| BridgeBio Pharma, Inc. BBIO | 50 | $80K |
| Alnylam Pharmaceuticals Inc. ALNY | 64 | $75K |
| CVRx, Inc. CVRX | 73 | $47K |
| Abbott Laboratories ABT | 89 | $27K |
| Lilly USA, LLC LLY | 13 | $17K |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $9,493 |
| Merck Sharp & Dohme LLC MRK | 10 | $149 |
| Boston Scientific Corporation BSX | 2 | $82.23 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $53.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.